Medical Devices

Biography

Biography: Pratap Kumar

Abstract

Introduction Heavy menstrual bleeding (HMB) is an important cause of ill health in women and it accounts for 12% of all gynecology referrals in the UK. Hysterectomy is often used to treat women with this complaint but medical therapy may be a successful alternative. The intrauterine Progesterone device was originally developed as a contraceptive but also resulted in a large reduction in menstrual blood loss. Hence, the use of the same in abnormal uterine bleeding was introduced. Material and Methods A total of 40 women were taken up for the study of Levonorgestrel Intra uterine system (MIRENA) with heavy menstrual bleeding after ruling out malignancy by uterine curettage. All the women had failure of medical treatment with oral progestogens. The duration of heavy menstrual bleeding was between 2 – 4 years. There were 15, 20 and 5 women with Dysfunctional uterine bleeding, Adenomyosis, and endometriosis respectively. Irrespective of the diagnosis control of bleeding was seen in 90% of cases. Menstrual blood loss was significantly reduced in 23 (57.5%) women and 15(37.5%) had complete amenorrhea. Of the 40 patients irregular spotting was seen in all women for duration of one to two months. Displacement was into cervical canal was seen in two women and both underwent hysterectomy as the bleeding continued heavily. Conclusions The LNG-IUS was the more effective first choice for management of menorrhagia compared with conventional medical treatment. More women were satisfied with the LNG-IUS and hysterectomy has been avoided in most of them.